NCT02197832

Brief Summary

This is a randomised controlled trial on the effect of endometrial injury in the cycle preceding the frozen-thawed embryo transfer (FET) cycles. The study hypothesis is that endometrial injury will increase the ongoing pregnancy rate in FET cycles.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

July 20, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 23, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

December 11, 2015

Status Verified

December 1, 2015

Enrollment Period

2.5 years

First QC Date

July 20, 2014

Last Update Submit

December 10, 2015

Conditions

Keywords

Frozen thawed embryo transferEndometrial injuryOngoing pregnancy rates

Outcome Measures

Primary Outcomes (1)

  • Ongoing pregnancy rate

    Pregnancy at 10-12 weeks

    pregnancy at 10-12 weeks

Secondary Outcomes (2)

  • Implantation rate

    4-6 weeks after embryo transfer

  • Clinical pregnancy rate

    6 weeks after embryo transfer

Study Arms (2)

EA

EXPERIMENTAL

in the cycle immediately preceding the scheduled FET treatment, an endometrial biopsy would be arranged on day 21-23 of the menstrual cycles and they will be instructed to use non-hormonal means of contraception during that cycle.

Procedure: Endometrial biopsy

Control

PLACEBO COMPARATOR

The procedure was performed in a standard approach using a Pipelle catheter (Pipelle de Cornier, Laboratoire C.C.D., France). The pipelle catheter was introduced through the cervix but not into the uterine cavity, only entering the endocervical canal as control.

Procedure: control procedureDevice: Pipelle catheter (Pipelle de Cornier, Laboratoire C.C.D., France)

Interventions

The procedure was performed in a standard approach using a Pipelle catheter (Pipelle de Cornier, Laboratoire C.C.D., France). The pipelle catheter was introduced through the cervix up to the uterine fundus. The piston was drawn back to the end of the sheath to create a negative pressure. The sheath was rotated and moved back and forth between the fundus and internal os for at least 3-4 times before it was gently withdrawn.

EA

Using pipelle catheter without entering the uterine cavity.

Control

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Undergoing FET treatment cycles
  • Normal uterine cavity as shown on transvaginal scanning or saline sonogram done at baseline
  • endometrial thickness \>=8mm during the stimulated IVF cycle and FET cycle

You may not qualify if:

  • Pregnancy in previous IVF or FET cycles
  • Presence of hydrosalpinx not surgically corrected prior to FET
  • Presence of endometrial polyp or fibroid distorting uterine cavity
  • IVF cycles carried out for preimplantation genetic diagnosis
  • Arrange for blastocyst transfer
  • Use of donor oocytes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Mary Hospital

Hong Kong, Hong Kong, 852, Hong Kong

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Vivian CY Lee, MBBS

    Queen Mary Hospital / University of Hong Kong.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2014

First Posted

July 23, 2014

Study Start

September 1, 2012

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

December 11, 2015

Record last verified: 2015-12

Locations